Latest News about Briefs
Recent news which mentions Briefs
From Benzinga
From Benzinga
From Benzinga
EXCLUSIVE: La Rosa Q3 Revenue Jumps 188%, CEO Eyes $100 Million Revenue Run Rate By 2024
November 20, 2024
From Benzinga
What's Going On With VinFast Auto Stock Today?
November 20, 2024
From Benzinga
Target Q3 Earnings: Supply Chain Chaos Hits Bottomline, Slashes Annual Profit Outlook, Stock Tanks
November 20, 2024
From Benzinga
Dycom Industries Posts Strong Q3 Results: EPS Beats Estimates By 14%
November 20, 2024
From Benzinga
NIO Q3 Earnings: 11.6% Gain In Vehicle Deliveries, Margins Improve, Issues Robust Q4 Delivery Outlook
November 20, 2024
From Benzinga
Asia Mixed, Europe Markets Gain; Gold Slips And Dollar Gains Against Yen - Global Markets Today While US Slept
November 20, 2024
From Benzinga
Wix Q3 Earnings: Revenue Surge, Margin Expansion, AI Momentum, Raised FY24 Guidance & More
November 20, 2024
From Benzinga
Fortinet Targets 45% Growth-Margin Combo, $450 Million Refresh Boost: Analysts See Big Upside
November 19, 2024
From Benzinga
Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
November 19, 2024
From Benzinga
Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
November 19, 2024
From Benzinga
Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst
November 19, 2024
From Benzinga
BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
November 19, 2024
From Benzinga
From Benzinga
Septerna Poised For Biopharma Breakthrough: Analysts Cite GPCR Innovation And 2025 Milestones
November 19, 2024
From Benzinga
Bitdeer Technologies' Strong Growth Potential Highlighted By Analysts Amid Bitcoin Bull Market
November 19, 2024
From Benzinga
From Benzinga
Kingsoft Cloud Q3 Earnings: Revenue Surges 16%, AI Growth Fuels Profits, CEO Shares Optimistic Outlook
November 19, 2024
From Benzinga
GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
November 19, 2024
From Benzinga
Joby Aviation Positioned For Air Taxi Leadership, Thanks To FAA Backing And Uber Partnership: Analyst
November 19, 2024
From Benzinga
Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients
November 19, 2024
From Benzinga
From Benzinga
Why Is Fusion Fuel Green Stock Falling Today?
November 19, 2024
From Benzinga
From Benzinga
Nvidia's Collaboration with Google AI Advances Next-Gen Quantum Hardware
November 19, 2024
From Benzinga
Robinhood Targets Affluent Investors With $300 Million TradePMR Deal
November 19, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.